Likewise, when the expression of Asp421-cleaved tau was assessed (Fig. 3g), we found more subjects with synucleinopathies and pancreatic truncated tau deposits than subjects with a normal neuropathological examination with (p = 0.0010) or without (p < 0.0001) T2DM history. This evidence concerns the gene MAPT and synucleinopathy.